News

January 18, 2021January 18, 2021

FDA Approves Generic Version of Celebrex

News

The U.S. Food and Drug Administration (FDA) has approved a generic version of Pfizer‘s Celebrex (celecoxib), an oral medication used to treat inflammation and pain caused by ankylosing spondylitis and ... Read more

January 12, 2021January 12, 2021

NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum

News, syndicated

The National Organization for Rare Disorders (NORD) is seeking individuals willing to share real-life experiences with rare diseases to speak at its upcoming virtual Living Rare, Living Stronger NORD Patient ... Read more

January 11, 2021January 11, 2021

Targeting Calcium‐sensing Receptor May Help Slow Disease Progression

News

Targeting the calcium‐sensing receptor (CaSR), which plays a critical role in the development of bone cells, may be a therapeutic strategy to slow the progression of ankylosing spondylitis (AS), a ... Read more

January 4, 2021January 4, 2021

Cosentyx Shown to Reduce Fatigue for Up to 3 Years in Active AS Patients

News

Treatment with Cosentyx (secukinumab) reduced fatigue for up to three years in people with active ankylosing spondylitis (AS), particularly those who had never received TNF inhibitors, according to two Phase ... Read more

December 21, 2020December 21, 2020

Sex Differences Found in nr-axSpA Disease Severity, Treatment Response

News

Among people with non-radiographic axial spondyloarthritis (nr-axSpA) — a type of arthritis that mainly affects the joints of the spine — women tend to have more severe disease than men ... Read more

December 14, 2020December 14, 2020

Rinvoq Recommended for EU Approval to Treat Active AS

News

AbbVie’s Rinvoq (upadacitinib) has been recommended for approval in the European Union as a treatment for active ankylosing spondylitis (AS) in adults. The Committee for Medicinal Products for Human Use ... Read more

December 7, 2020December 7, 2020

Humira Biosimilar AVT02 Accepted for Regulatory Review in US, Europe

News

The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted and agreed to review applications seeking approval of AVT02, a Humira (adalimumab) biosimilar candidate. The FDA ... Read more

December 1, 2020December 1, 2020

NORD Push for Rare Disease Advisory Councils Focus of Dec. 16 Public Meeting

News, syndicated

To empower and equip members of the rare disease community to engage state leaders in matters of importance to patients and their families, the National Organization for Rare Disorders (NORD) ... Read more

November 23, 2020November 23, 2020

Survey Finds COVID-19 Disrupted Care, Well-Being of Rare Disease Patients in Europe

News, syndicated

The first wave of COVID-19 in Europe severely disrupted access to care and raised stress and anxiety in people with rare diseases, negatively affecting their health and well-being, according to a ... Read more

November 19, 2020November 19, 2020

Latest NORD Webinar Offers Insights on Starting Nonprofit, Patient Registry

News, syndicated

Leaders in the U.S. rare disease community came together recently for a webinar to present helpful information on how to start a nonprofit and patient registry. They shared about how ... Read more